Loading...

José Aynat

PharmD, MBA

Harvard Senior Executive Fellow 2025

Lentistem Biotech is an R&D biotechnology company which designs and produces therapeutic lentiviral vectors. Our MISSION is to develop new technologies to improve the efficacy and safety of cancer immunotherapy (CAR-T cells).

Subscribe to our newsletter

I have read and agree to receive informational and commercial communications from LentiStem SL. You can unsubscribe at any time using the link included in each email. We process your email to manage your subscription and send communications in accordance with our Privacy Policy.

Useful Links

Home
About Us
Our Science
Collaborators
Our Team
News
Contact

Terms & Conditions
Privacy Policy

Our Platforms

TCR-like Platform
Lent-On-Plus Platform

Socials

LinkedIn
X (Twitter)
Facebook

Contact Us

info@lentistem.com

Top